Charles S. Tannenbaum

3.5k total citations
59 papers, 2.9k citations indexed

About

Charles S. Tannenbaum is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Charles S. Tannenbaum has authored 59 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Immunology, 26 papers in Molecular Biology and 24 papers in Oncology. Recurrent topics in Charles S. Tannenbaum's work include Immunotherapy and Immune Responses (20 papers), Immune Cell Function and Interaction (11 papers) and Immune cells in cancer (11 papers). Charles S. Tannenbaum is often cited by papers focused on Immunotherapy and Immune Responses (20 papers), Immune Cell Function and Interaction (11 papers) and Immune cells in cancer (11 papers). Charles S. Tannenbaum collaborates with scholars based in United States, India and Japan. Charles S. Tannenbaum's co-authors include Thomas A. Hamilton, James H. Finke, Ronald M. Bukowski, Patricia Rayman, David A. Armstrong, Raymond Tubbs, Tanya Das, Dolph O. Adams, Kaushik Biswas and Andrew C. Novick and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Charles S. Tannenbaum

59 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charles S. Tannenbaum United States	32	1.8k	1.2k	976	295	286	59	2.9k
Gerald M. Feldman United States	27	1.3k 0.8×	1.2k 1.0×	1.2k 1.2×	336 1.1×	135 0.5×	59	2.9k
Hiro Wakasugi Japan	33	1.7k 0.9×	1.1k 0.9×	1.5k 1.5×	499 1.7×	158 0.6×	90	3.6k
Karlheinz Friedrich Germany	31	1.0k 0.6×	1.1k 1.0×	1.4k 1.4×	425 1.4×	380 1.3×	78	3.2k
Alexandre Corthay Norway	28	2.1k 1.2×	1.2k 1.0×	794 0.8×	237 0.8×	229 0.8×	53	3.2k
Jennifer Major United States	26	1.5k 0.9×	597 0.5×	893 0.9×	428 1.5×	190 0.7×	37	2.9k
Yoshimoto Katsura Japan	30	3.1k 1.8×	729 0.6×	1.3k 1.3×	181 0.6×	179 0.6×	72	4.6k
S. Jaharul Haque United States	28	981 0.6×	980 0.8×	1.0k 1.1×	433 1.5×	257 0.9×	58	2.5k
Subburaj Ilangumaran Canada	35	1.5k 0.8×	1.1k 0.9×	1.6k 1.6×	306 1.0×	203 0.7×	101	3.6k
Shuhua Han United States	30	2.2k 1.3×	522 0.4×	910 0.9×	295 1.0×	164 0.6×	82	3.6k
Véronique Baron France	33	1.1k 0.6×	772 0.6×	2.0k 2.1×	463 1.6×	214 0.7×	57	3.7k

Countries citing papers authored by Charles S. Tannenbaum

Since Specialization

Citations

This map shows the geographic impact of Charles S. Tannenbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles S. Tannenbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles S. Tannenbaum more than expected).

Fields of papers citing papers by Charles S. Tannenbaum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles S. Tannenbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles S. Tannenbaum. The network helps show where Charles S. Tannenbaum may publish in the future.

Co-authorship network of co-authors of Charles S. Tannenbaum

This figure shows the co-authorship network connecting the top 25 collaborators of Charles S. Tannenbaum. A scholar is included among the top collaborators of Charles S. Tannenbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles S. Tannenbaum. Charles S. Tannenbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pavicic, Paul G., Patricia Rayman, Shadi Swaidani, et al.. (2023). Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppression. OncoImmunology. 12(1). 2198185–2198185. 9 indexed citations

Tannenbaum, Charles S., Patricia Rayman, Paul G. Pavicic, et al.. (2019). Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs. Cancer Immunology Research. 7(10). 1687–1699. 39 indexed citations

Sun, Lillian, Pauline Funchain, Jung Min Song, et al.. (2018). Talimogene Laherparepvec combined with anti-PD-1 based immunotherapy for unresectable stage III-IV melanoma: a case series. Journal for ImmunoTherapy of Cancer. 6(1). 36–36. 74 indexed citations

Mahata, Barun, Patricia Rayman, Ali Chahlavi, et al.. (2015). GBM Derived Gangliosides Induce T Cell Apoptosis through Activation of the Caspase Cascade Involving Both the Extrinsic and the Intrinsic Pathway. PLoS ONE. 10(7). e0134425–e0134425. 21 indexed citations

Sa, Gaurisankar, Tanya Das, Christina Moon, et al.. (2009). GD3, an Overexpressed Tumor-Derived Ganglioside, Mediates the Apoptosis of Activated but not Resting T Cells. Cancer Research. 69(7). 3095–3104. 55 indexed citations

Biswas, Kaushik, Amy L. Richmond, Jennifer S. Ko, et al.. (2009). Elevated Levels of Select Gangliosides in T Cells from Renal Cell Carcinoma Patients Is Associated with T Cell Dysfunction. The Journal of Immunology. 183(8). 5050–5058. 40 indexed citations

Das, Tanya, Gaurisankar Sa, Daisuke Kudo, et al.. (2008). GM1 and Tumor Necrosis Factor-α, Overexpressed in Renal Cell Carcinoma, Synergize to Induce T-Cell Apoptosis. Cancer Research. 68(6). 2014–2023. 30 indexed citations

Gorbachev, Anton V., Hirohito Kobayashi, Daisuke Kudo, et al.. (2007). CXC Chemokine Ligand 9/Monokine Induced by IFN-γ Production by Tumor Cells Is Critical for T Cell-Mediated Suppression of Cutaneous Tumors. The Journal of Immunology. 178(4). 2278–2286. 93 indexed citations

Kudo, Daisuke, Patricia Rayman, Luis Moltó, et al.. (2004). Degradation of NF-κB in T Cells by Gangliosides Expressed on Renal Cell Carcinomas. The Journal of Immunology. 172(6). 3480–3490. 35 indexed citations

10.

Dorsey, Russell, Namita Kundu, Qingyuan Yang, et al.. (2002). Immunotherapy with interleukin-10 depends on the CXC chemokines inducible protein-10 and monokine induced by IFN-gamma.. PubMed. 62(9). 2606–10. 42 indexed citations

11.

Watarai, Yoshihiko, Shoji Koga, David R. Paolone, et al.. (2000). Intraallograft Chemokine RNA and Protein During Rejection of MHC-Matched/Multiple Minor Histocompatibility-Disparate Skin Grafts. The Journal of Immunology. 164(11). 6027–6033. 46 indexed citations

12.

Tannenbaum, Charles S. & Thomas A. Hamilton. (2000). Immune-inflammatory mechanisms in IFNγ-mediated anti-tumor activity. Seminars in Cancer Biology. 10(2). 113–123. 67 indexed citations

13.

Tannenbaum, Charles S., Raymond Tubbs, David A. Armstrong, et al.. (1998). The CXC Chemokines IP-10 and Mig Are Necessary for IL-12-Mediated Regression of the Mouse RENCA Tumor. The Journal of Immunology. 161(2). 927–932. 245 indexed citations

14.

Tannenbaum, Charles S., David A. Armstrong, R Tubbs, et al.. (1996). Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12. The Journal of Immunology. 156(2). 693–699. 142 indexed citations

15.

Tannenbaum, Charles S., Jennifer Major, & Thomas A. Hamilton. (1993). IFN-gamma and lipopolysaccharide differentially modulate expression of tumor necrosis factor receptor mRNA in murine peritoneal macrophages.. The Journal of Immunology. 151(12). 6833–6839. 35 indexed citations

16.

Thiel, Bonnie, et al.. (1993). Synergistic cooperation between T cell lymphokines for induction of the nitric oxide synthase gene in murine peritoneal macrophages.. The Journal of Immunology. 151(1). 322–329. 117 indexed citations

17.

Tannenbaum, Charles S. & Michael Largen. (1990). The correlation between specific protein synthesis and tumoricidal function in murine peritoneal macrophages. Cellular Immunology. 131(1). 52–66. 1 indexed citations

18.

Tannenbaum, Charles S., T J Koerner, M. Jansen, & Thomas A. Hamilton. (1988). Characterization of lipopolysaccharide-induced macrophage gene expression.. The Journal of Immunology. 140(10). 3640–3645. 83 indexed citations

19.

Koerner, T J, Thomas A. Hamilton, Martino Introna, et al.. (1987). The early competence genes JE and KC are differentially regulated in murine peritoneal macrophages in response to lipopolysaccharide. Biochemical and Biophysical Research Communications. 149(3). 969–974. 26 indexed citations

20.

Tannenbaum, Charles S., Annette T. Hastie, M L Higgins, Friedrich Kueppers, & George Weinbaum. (1984). Inability of purified Pseudomonas aeruginosa exopolysaccharide to bind selected antibiotics. Antimicrobial Agents and Chemotherapy. 25(6). 673–675. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact